Taken together, these data demonstrate that IRF1 has a dual role in BV6-mediated signaling: It acts as a proapoptotic factor in cell death induction and also affects the interaction of tumor cells with their microenvironment by promoting the secretion of cytokines and attraction of immune cells. The gene discussed is IRF1; the disease is neoplasm.